UltraTech Cement Limited
UltraTech Cement Limited (UCLQF) Financial Performance & Income Statement Overview
Explore the financials of UltraTech Cement Limited (UCLQF), including yearly and quarterly data on income, cash flow, and balance sheets.
UltraTech Cement Limited (UCLQF) Income Statement & Financial Overview
Analyze UltraTech Cement Limited’s UCLQF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $250.58B | $171.93B | $156.35B | $180.70B |
| Cost of Revenue | $42.67B | $32.96B | $29.16B | $92.98B |
| Gross Profit | $207.90B | $138.97B | $127.18B | $87.71B |
| Gross Profit Ratio | $0.83 | $0.81 | $0.81 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $58.84B | $38.11B | $35.84B | $49.20B |
| Operating Expenses | $175.29B | $119.27B | $116.04B | $65.42B |
| Total Costs & Expenses | $217.97B | $152.23B | $145.20B | -$158.40B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6.96B | $3.82B | $3.17B | $2.56B |
| Depreciation & Amortization | $13.52B | $9.17B | $9.04B | $8.43B |
| EBITDA | $45.86B | $31.30B | $22.38B | $32.38B |
| EBITDA Ratio | $0.18 | $0.18 | $0.14 | $0.18 |
| Operating Income | $32.61B | $19.70B | $11.14B | $22.29B |
| Operating Income Ratio | $0.13 | $0.11 | $0.07 | $0.12 |
| Other Income/Expenses (Net) | -$7.23B | -$1.39B | -$978.40M | -$898.10M |
| Income Before Tax | $25.38B | $18.32B | $10.17B | $21.39B |
| Income Before Tax Ratio | $0.10 | $0.11 | $0.07 | $0.12 |
| Income Tax Expense | $4.92B | $3.58B | $1.91B | $4.47B |
| Net Income | $20.53B | $14.70B | $8.20B | $16.97B |
| Net Income Ratio | $0.08 | $0.09 | $0.05 | $0.09 |
| EPS | $84.38 | $50.99 | $28.45 | $58.85 |
| Diluted EPS | $84.38 | $50.94 | $28.43 | $58.82 |
| Weighted Avg Shares Outstanding | $294.15M | $288.20M | $288.24M | $288.28M |
| Weighted Avg Shares Outstanding (Diluted) | $294.15M | $288.48M | $288.44M | $288.44M |
Financial performance has remained strong, with revenue growing from $180.70B in Q4 2024 to $250.58B in Q3 2025. Gross profit continued to perform well, with margins at 83% in the latest quarter. Operating income reached $32.61B in Q3 2025, holding a steady 13% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $45.86B. Net income rose to $20.53B, keeping EPS at $84.38. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan